Additionally, activation of glycolysis via GLUT3 and phosphofructokinase overexpression in motor neurons was neuroprotective and improved locomotion in a TDP-43 Drosophila model, suggesting that glycolysis activators could slow disease progression and prolong survival in ALS [85]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.